These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 3510799

  • 1. Regional blood flow and neurohormonal responses to milrinone in congestive heart failure.
    Cody RJ, Kubo SH, Covit AB, Müller FB, Rutman H, Leonard D, Laragh JH, Feldschuh J, Preibisz J.
    Clin Pharmacol Ther; 1986 Feb; 39(2):128-35. PubMed ID: 3510799
    [Abstract] [Full Text] [Related]

  • 2. Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.
    Maskin CS, Sinoway L, Chadwick B, Sonnenblick EH, Le Jemtel TH.
    Circulation; 1983 May; 67(5):1065-70. PubMed ID: 6831672
    [Abstract] [Full Text] [Related]

  • 3. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS, Wright RF, Jaski BE, Fifer MA, Braunwald E.
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [Abstract] [Full Text] [Related]

  • 4. Preload-dependent hemodynamic effects of milrinone in moderate heart failure.
    Remme WJ, van Hoogenhuyze DC, Kruijssen HA, Pieper PG, Bruggeling WA.
    Cardiology; 1992 Mar; 80(2):132-42. PubMed ID: 1611632
    [Abstract] [Full Text] [Related]

  • 5. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure.
    Monrad ES, Baim DS, Smith HS, Lanoue A, Brauwald E, Grossman W.
    Circulation; 1985 May; 71(5):972-9. PubMed ID: 3986984
    [Abstract] [Full Text] [Related]

  • 6. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension.
    Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS.
    J Am Coll Cardiol; 1996 Dec; 28(7):1775-80. PubMed ID: 8962566
    [Abstract] [Full Text] [Related]

  • 7. Renal and hormonal effects of phosphodiesterase III inhibition in congestive heart failure.
    Cody RJ.
    Am J Cardiol; 1989 Jan 03; 63(2):31A-34A. PubMed ID: 2642628
    [Abstract] [Full Text] [Related]

  • 8. Identification of the direct vasodilator effect of milrinone with an isolated limb preparation in patients with chronic congestive heart failure.
    Cody RJ, Müller FB, Kubo SH, Rutman H, Leonard D.
    Circulation; 1986 Jan 03; 73(1):124-9. PubMed ID: 3940663
    [Abstract] [Full Text] [Related]

  • 9. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
    Jaski BE, Fifer MA, Wright RF, Braunwald E, Colucci WS.
    J Clin Invest; 1985 Feb 03; 75(2):643-9. PubMed ID: 3973022
    [Abstract] [Full Text] [Related]

  • 10. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
    Liang CS, Thomas A, Imai N, Stone CK, Kawashima S, Hood WB.
    J Cardiovasc Pharmacol; 1987 Nov 03; 10(5):509-16. PubMed ID: 2447398
    [Abstract] [Full Text] [Related]

  • 11. Hemodynamic and regional blood flow response to captopril in congestive heart failure.
    Levine TB, Olivari MT, Cohn JN.
    Am J Med; 1984 May 31; 76(5B):38-42. PubMed ID: 6375361
    [Abstract] [Full Text] [Related]

  • 12. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
    Mager G, Klocke RK, Kux A, Höpp HW, Hilger HH.
    Am Heart J; 1991 Jun 31; 121(6 Pt 2):1974-83. PubMed ID: 1852090
    [Abstract] [Full Text] [Related]

  • 13. Hemodynamic effects of i.v. milrinone lactate in pediatric patients with septic shock. A prospective, double-blinded, randomized, placebo-controlled, interventional study.
    Barton P, Garcia J, Kouatli A, Kitchen L, Zorka A, Lindsay C, Lawless S, Giroir B.
    Chest; 1996 May 31; 109(5):1302-12. PubMed ID: 8625683
    [Abstract] [Full Text] [Related]

  • 14. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure.
    Faxon DP, Creager MA, Halperin JL, Bernard DB, Ryan TJ.
    Am J Med; 1984 May 31; 76(5B):104-10. PubMed ID: 6203405
    [Abstract] [Full Text] [Related]

  • 15. [Central and regional vascular hemodynamics of milrinone in experimental heart failure: comparison with captopril and dobutamine].
    Drexler H, Faude F, Winterer H, Wollschläger H, Freudenberg N, Just H.
    Z Kardiol; 1987 Aug 31; 76(8):507-13. PubMed ID: 3314215
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Central and renal hemodynamic effects of a new agonist at peripheral dopamine- and beta-2 adrenoreceptors (dopexamine) in patients with heart failure.
    Jamison M, Widerhorn J, Weber L, Campese V, Vasquez J, Hovanessian L, Rahimtoola SH, Elkayam U.
    Am Heart J; 1989 Mar 31; 117(3):607-14. PubMed ID: 2537556
    [Abstract] [Full Text] [Related]

  • 19. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
    Leier CV, Patrick TJ, Hermiller J, Pacht KD, Huss P, Magorien RD, Unverferth DV.
    Am Heart J; 1984 Dec 31; 108(6):1461-8. PubMed ID: 6507242
    [Abstract] [Full Text] [Related]

  • 20. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.
    Pamboukian SV, Carere RG, Webb JG, Cook RC, D'yachkova Y, Abel JG, Ignaszewski AP.
    J Heart Lung Transplant; 1999 Apr 31; 18(4):367-71. PubMed ID: 10226902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.